Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.

Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, Tosco L, Van Poppel H, Claessens F.

Biomed Res Int. 2014;2014:627510. doi: 10.1155/2014/627510. Epub 2014 Feb 19.

PMID:
24701578
[PubMed - in process]
Free PMC Article
2.

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.

Xu J.

Asian J Androl. 2014 Jul-Aug;16(4):536-40. doi: 10.4103/1008-682X.125907. No abstract available.

PMID:
24625885
[PubMed - in process]
Free PMC Article
3.

Prostate cancer risk-associated genetic markers and their potential clinical utility.

Xu J, Sun J, Zheng SL.

Asian J Androl. 2013 May;15(3):314-22. doi: 10.1038/aja.2013.42. Epub 2013 Apr 8.

PMID:
23564047
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Utility of single nucleotide polymorphisms in prostate biopsy decisions.

Loeb S, Braithwaite RS, Hayes RB.

Rev Urol. 2012;14(3-4):115-7. No abstract available.

PMID:
23526876
[PubMed]
Free PMC Article
5.

Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history.

Sun J, Na R, Hsu FC, Zheng SL, Wiklund F, Condreay LD, Trent JM, Xu J.

Eur Urol. 2013 Mar;63(3):585-7. doi: 10.1016/j.eururo.2012.11.047. Epub 2012 Dec 5. No abstract available.

PMID:
23245817
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.

Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J.

Genet Epidemiol. 2012 Jan;36(1):71-83. doi: 10.1002/gepi.21600.

PMID:
22890972
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.

Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB Jr, Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, Lane BR, Isaacs WB, Meyers DA, Bleecker ER, Torti FM, Trent JM, McConnell JD, Zheng SL, Condreay LD, Rittmaster RS, Xu J.

Eur Urol. 2012 Dec;62(6):953-61. doi: 10.1016/j.eururo.2012.05.006. Epub 2012 May 12.

PMID:
22652152
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inherited susceptibility for aggressive prostate cancer.

Isaacs WB.

Asian J Androl. 2012 May;14(3):415-8. doi: 10.1038/aja.2011.146. Epub 2012 Apr 30. Review.

PMID:
22543676
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.

Turner AR, Kader AK, Xu J.

J Intern Med. 2012 Apr;271(4):344-52. doi: 10.1111/j.1365-2796.2012.02522.x.

PMID:
22272820
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers.

Heald B, Edelman E, Eng C.

Eur J Hum Genet. 2012 May;20(5):547-51. doi: 10.1038/ejhg.2011.224. Epub 2012 Jan 4.

PMID:
22215421
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Predicting prostate cancer many years before diagnosis: how and why?

Vickers AJ, Lilja H.

World J Urol. 2012 Apr;30(2):131-5. doi: 10.1007/s00345-011-0795-8. Epub 2011 Nov 20.

PMID:
22101902
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.

Jin G, Sun J, Liu W, Zhang Z, Chu LW, Kim ST, Sun J, Feng J, Duggan D, Carpten JD, Wiklund F, Grönberg H, Isaacs WB, Zheng SL, Xu J.

Carcinogenesis. 2011 Jul;32(7):1057-62. doi: 10.1093/carcin/bgr082. Epub 2011 May 5.

PMID:
21551127
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.

Lu Y, Zhang Z, Yu H, Zheng SL, Isaacs WB, Xu J, Sun J.

Prostate. 2011 Jun 15;71(9):955-63. doi: 10.1002/pros.21311. Epub 2010 Dec 6.

PMID:
21541972
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effects of family history and genetic polymorphism on the cost-effectiveness of chemoprevention with finasteride for prostate cancer.

Reed SD, Scales CD Jr, Stewart SB, Sun J, Moul JW, Schulman KA, Xu J.

J Urol. 2011 Mar;185(3):841-7. doi: 10.1016/j.juro.2010.10.078. Epub 2011 Jan 15.

PMID:
21239023
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer.

Sun J, Kader AK, Hsu FC, Kim ST, Zhu Y, Turner AR, Jin T, Zhang Z, Adolfsson J, Wiklund F, Zheng SL, Isaacs WB, Grönberg H, Xu J.

Prostate. 2011 Mar 1;71(4):421-30. doi: 10.1002/pros.21256. Epub 2010 Sep 28.

PMID:
20878950
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.

Helfand BT, Kan D, Modi P, Catalona WJ.

Prostate. 2011 Mar 1;71(4):394-402. doi: 10.1002/pros.21253. Epub 2010 Sep 21.

PMID:
20860009
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.

Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, Catalona WJ.

J Urol. 2010 Aug;184(2):501-5. doi: 10.1016/j.juro.2010.04.032. Epub 2010 Jun 17.

PMID:
20620408
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation.

Kim ST, Cheng Y, Hsu FC, Jin T, Kader AK, Zheng SL, Isaacs WB, Xu J, Sun J.

Prostate. 2010 Dec 1;70(16):1729-38. doi: 10.1002/pros.21208.

PMID:
20564319
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.

Schumacher FR, Cheng I, Freedman ML, Mucci L, Allen NE, Pollak MN, Hayes RB, Stram DO, Canzian F, Henderson BE, Hunter DJ, Virtamo J, Manjer J, Gaziano JM, Kolonel LN, Tjønneland A, Albanes D, Calle EE, Giovannucci E, Crawford ED, Haiman CA, Kraft P, Willett WC, Thun MJ, Le Marchand L, Kaaks R, Feigelson HS, Bueno-de-Mesquita HB, Palli D, Riboli E, Lund E, Amiano P, Andriole G, Dunning AM, Trichopoulos D, Stampfer MJ, Key TJ, Ma J.

Hum Mol Genet. 2010 Aug 1;19(15):3089-101. doi: 10.1093/hmg/ddq210. Epub 2010 May 19.

PMID:
20484221
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Hsu FC, Sun J, Zhu Y, Kim ST, Jin T, Zhang Z, Wiklund F, Kader AK, Zheng SL, Isaacs W, Grönberg H, Xu J.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1083-8. doi: 10.1158/1055-9965.EPI-09-1176. Epub 2010 Mar 23.

PMID:
20332264
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk